Capitaline

Corporate News 21-Nov-17

Ajanta Pharma gets approval for Clonidine Hydrochloride Extended Release Tablets

From USFDA

Ajanta Pharma announced that the Company has received the final approval for Clonidine Hydrochloride Extended Release Tablets from US FDA and the same has been launched in US Market through its wholly owned subsidiary, Ajanta Pharma USA Inc.

It is a bioequivalent generic version of Kapvay®1 Tablets and company has launched the product in 0.1mg dosage

Previous News

Ajanta Pharma
( Results - Analysis 31-Oct-23 23:40 )

Ajanta Pharma gains after receiving USFDA approval for Topiramate capsules
( Hot Pursuit - 31-Aug-23 09:32 )

Volumes spurt at Shriram Finance Ltd counter
( Hot Pursuit - 08-Mar-23 11:00 )

Volumes spurt at Ajanta Pharma Ltd counter
( Hot Pursuit - 20-Oct-23 11:00 )

Volumes soar at Ajanta Pharma Ltd counter
( Hot Pursuit - 23-Feb-22 14:30 )

Ajanta Pharma Ltd leads losers in 'A' group
( Hot Pursuit - 04-Nov-22 15:00 )

Ajanta Pharma to conduct board meeting
( Corporate News - 22-Oct-22 13:40 )

Ajanta Pharma standalone net profit declines 27.29% in the March 2018 quarter
( Results - Announcements 03-May-18 16:02 )

Ajanta Pharma fixes record date for buyback of shares
( Market Beat - Reports 28-Dec-21 14:39 )

Ajanta Pharma consolidated net profit declines 4.93% in the September 2018 quarter
( Results - Announcements 31-Oct-18 17:07 )

Ajanta Pharma
( Results - Analysis 10-May-22 16:35 )

Other Stories

Vardhan Capital & Finance schedules AGM
06-Jul-24 17:34

Automotive Axles schedules AGM
06-Jul-24 17:34

Maruti Infrastructure to conduct AGM
06-Jul-24 17:34

Torrent Power schedules AGM
06-Jul-24 17:34

Raghav Productivity Enhancers to hold AGM
06-Jul-24 17:34

Berger Paints India schedules AGM
06-Jul-24 17:33

Walpar Nutritions to conduct AGM
06-Jul-24 17:33

Weizmann AGM scheduled
06-Jul-24 17:33

Gretex Industries schedules AGM
06-Jul-24 17:33

Karma Energy schedules AGM
06-Jul-24 17:33

Back

Top